Diabetes Should Be a Factor in Weight-Loss Surgery Decision: Study: – THURSDAY, Sept. 17, 2015 – – Obese patients with type 2 diabetes might reap better health-care savings after weight-loss surgery than obese sufferers without diabetes, researchers say. Most health-care systems use a higher body mass index to prioritize individuals for weight-loss medical procedures http://www.sildenafilcitrate.net/what-buyers-need-to-know-about-intagra . BMI can be a way of measuring body fat predicated on height and weight. But experts who tracked a large number of obese Swedes for 15 years concluded that if containing health costs may be the goal, type 2 diabetes then, especially newly diagnosed cases, should be added to the reason why to consider weight-loss surgery.
The ‘gold standard’ pancreatic cancer biomarker would possess both high sensitivity and specificity for early diagnosis. Cancers, at its most elementary, is an abnormal people of cells that create particular molecules – biomarkers – which healthful, cancer-free bodies usually do not. Cancer is commonly incipient also, Pandey says. The perfect biomarker allows for easy diagnosis when a cancer is still youthful, before it spreads to additional organs. It might also help clinicians make informed decisions about remedies and better predict of outcomes, Pandey says: ‘Biomarkers could tell us who should undergo medical procedures, who should get chemotherapy, and in which people a cancer will probably recur.’ Biomarker discovery can be an exploding area of study, Pandey says, yielding ever-increasing levels of data – a lot more than any one person can hope to keep track of, unless it’s all strategically gathered for widespread research.